top of page

Women's Hormonal Health and the Role of Integrative Care

sobima-girl-7832382.jpg

Reframing Women's Health

Women's health has long been narrowly equated with reproductive health — antenatal care, contraception, and maternal mortality. The World Health Organization recognises that women's health extends well beyond reproduction, encompassing mental health, non-communicable diseases (NCDs), and endocrine-metabolic disorders, all of which intersect distinctly with female biology.

​

Within this broader framing, women's hormonal health refers to the health of the endocrine system as it functions across a woman's life — from puberty through reproductive years, perimenopause, and into post-menopause. The central conditions in this domain include polycystic ovary syndrome (PCOS), thyroid dysfunction, premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD), endometriosis, menopausal transition disorders, and adrenal-HPA axis dysregulation. All these conditions share their intimate dependence on lifestyle, environment, and psychosocial factors — making them especially amenable to integrative approaches.

The Scale of the Problem

The epidemiological burden of women's hormonal disorders is substantial and growing. PCOS — the most common endocrinopathy in reproductive-age women affects between 10% and 13% of women globally with 70% of them remaining undiagnosed. A GBD 2021 analysis estimated 65.8 million prevalent PCOS cases globally, with disability-adjusted life years (DALYs) increasing by 87% since 1990.PCOS burden has grown by 28% over three decades, with particularly high growth rates in middle sociodemographic index regions, where urbanisation and lifestyle transition are most rapid. The same study reported 21 million cases of Endometriosis and 890 million cases of premenstrual syndrome in 2021. Menopause carries significant cardiovascular, metabolic, and cognitive health implications increasingly shaped by lifestyle.

​

In India, an ICMR study found a PCOS prevalence of 19.6%, affecting nearly one in five Indian women of reproductive age. The metabolic comorbidity burden was alarming: 91.9% of affected women had dyslipidaemia, 43.2% had obesity, 32.9% had non-alcoholic fatty liver disease, 24.9% had metabolic syndrome, and 8.3% had hypertension. These findings confirm that PCOS in India is not only a reproductive condition, but also a metabolic disorder and its management demands a comprehensive, multi-pronged approach.

Lifestyle, Stress, and Hormonal Imbalance

The pathophysiology of women's hormonal disorders is multifactorial, operating across three interconnected axes: the hypothalamic-pituitary-ovarian (HPO) axis, which governs reproductive hormone production; the hypothalamic-pituitary-adrenal (HPA) axis, which regulates cortisol and the stress response; and the hypothalamic-pituitary-thyroid (HPT) axis, which governs metabolic rate and immune regulation. These axes are not independent — disruption to any one has cascading consequences for the others.

​

Insulin resistance is a well-established mechanism in PCOS pathophysiology. Hyperinsulinaemia — driven by high-glycaemic diets, physical inactivity, and visceral adiposity — stimulates ovarian androgen production and anovulation. Insulin resistance is present in approximately 70–80% of women with PCOS regardless of body weight, meaning lean women carry this metabolic risk too.

​

Chronic psychological stress operates through the HPA axis. Sustained cortisol elevation disrupts ovulation, competes with progesterone at shared receptor sites, producing relative progesterone deficiency even when serum levels appear normal. Cortisol also promotes visceral adiposity, which itself secretes oestrogens, inflammatory cytokines (IL-6, TNF-α), and leptin, sustaining androgen excess.

​

Circadian disruption is an underappreciated risk factor. Cortisol, insulin, melatonin, and reproductive hormones all follow tightly regulated diurnal rhythms. Shift work, late-night screen exposure, irregular sleep timing, and late eating impair insulin sensitivity, suppress melatonin, and destabilise the cortisol awakening response, with measurable downstream hormonal consequences.

​

Gut microbiome dysbiosis is an increasingly recognised contributor to women's hormonal disorders, operating through multiple pathways. In PCOS, gut microbiota regulates insulin synthesis, androgen metabolism, and follicular development, all of which are disrupted when microbial diversity is reduced. Dysbiosis increases intestinal permeability, allowing lipopolysaccharides to enter circulation and sustain the chronic low-grade inflammation that worsens insulin resistance and hyperandrogenism. The "estrobolome" — gut bacteria governing oestrogen metabolism is simultaneously impaired, further disturbing hormonal balance. High-glycaemic diets, physical inactivity, and chronic stress all deplete this diversity, making gut health a modifiable lever in hormonal restoration.

​

Endocrine-disrupting chemicals (EDCs) — including bisphenol A (from plastics), phthalates (from cosmetics and packaging), parabens, and organophosphate pesticides — interfere with oestrogen receptors, thyroid hormone signalling, and insulin pathways.

Emerging Evidence: Lifestyle Medicine, Yoga, Ayurveda, and Contemplative Practice

The 2023 International Evidence-Based Guideline for the Assessment and Management of PCOS recommends lifestyle intervention for all women with PCOS across the lifespan. The guideline emphasises that a supported healthy lifestyle is a core focus of management for improving metabolic health, quality of life, and emotional wellbeing, regardless of body weight. This positions lifestyle not as an adjunct, but as a foundational and universal component of care.

​

Evidence for specific lifestyle interventions is growing, though the quality varies across modalities. Low-glycaemic index diets improve insulin sensitivity and menstrual regularity in PCOS. A Mediterranean-style low-carbohydrate diet has been shown to restore menstrual cycles and reduce testosterone and LH. Aerobic exercise reduces insulin levels and testosterone; combined aerobic and resistance training improves both metabolic and body composition outcomes, and hence have implications on a wide variety of conditions. Sleep is a powerful and often neglected hormonal lever. Even one week of restriction to five hours significantly raises cortisol and impairs insulin sensitivity — making adequate, circadian-aligned sleep an essential component of hormonal management.

​

Yoga 

​

Yoga has an emerging and promising evidence base in PCOS, though the current literature remains limited. A meta-analysis found that yoga reduced fasting insulin, HOMA-IR, menstrual irregularity, and clinical hyperandrogenism in women with PCOS, though the evidence was graded as low quality. A 2026 systematic review of RCTs confirmed improvements across metabolic, endocrine, menstrual, and psychological outcomes — including insulin resistance, testosterone, LH, and body image — but could not perform a meta-analysis due to high heterogeneity across studies, and called for larger, standardised trials before firm conclusions can be drawn. Systematic reviews showed that Yoga significantly reduced menopausal symptoms and appears to be beneficial in premenstrual syndrome.

​

Ayurveda

​

Ayurveda offers a conceptually and clinically congruent framework. Ashwagandha (Withania somnifera) is the most studied herb in this context. A systematic review and meta-analysis of RCTs confirms significant reductions in perceived stress, anxiety, and serum cortisol — acting through modulation of the HPA axis. A single double-blind RCT in subclinical hypothyroidism (n=50, 8 weeks) showed significant improvements in TSH, T3, and T4, though larger trials are needed. Fenugreek (Trigonella foenum-graecum) has demonstrated glycaemic benefits, with emerging evidence of hormonal benefits in PCOS, though the latter is based on limited data. For menopause, a 2024 systematic review and meta-analysis evaluating Ayurvedic and Siddha interventions found promising evidence for symptom management, including somatic (hot flashes, night sweats, sleep disturbances) and psychological symptoms compared to placebo and conventional treatments. Additionally, positive effects on hormonal balance and quality of life were reported. A literature review of Ayurvedic herbs in female reproductive health further documents their application across dysmenorrhoea, PCOS, infertility, and endometriosis, though the latter conditions require larger, well-designed trials. Emerging research is beginning to document the scientific correlates of Ayurvedic personalisation: Prakriti (individual constitution) has been shown to align with genetic polymorphisms, metabolomic, and microbiome profiles in peer-reviewed studies, suggesting a biological basis for constitution-based care. Similarly, Dinacharya (Ayurvedic daily routine) — with its emphasis on wake timing, meal timing, and sleep-wake alignment — closely parallels the principles of modern chronobiology, a field whose relevance to hormonal regulation is now well established.

​

Meditation

​

Meditation is emerging as a neuroendocrine intervention with direct relevance to hormonal health. A randomised controlled trial demonstrated that Heartfulness meditation significantly increased oxytocin and β-endorphin levels while reducing cortisol.¹³ Given cortisol's central role in suppressing progesterone, disrupting ovulation, and sustaining insulin resistance, these effects have direct implications for women's hormonal health. A 2024 scoping review in Frontiers in Endocrinology (Rao et al.) found that meditation and mindfulness interventions improved psychological, metabolic, and quality-of-life outcomes, supporting their integration into PCOS management alongside conventional treatment.

Toward Convergence: The Case for an Integrative Response

Despite the weight of evidence, a significant gap persists between what the science supports and what women with hormonal disorders actually receive. The Ganie et al. (2024) India study found that only 9.1% of women with PCOS had received adequate information from their physicians. Most are managed with oral contraceptives or metformin in isolation — pharmacological management of a condition that is, at its root, a lifestyle and metabolic disease.

​

The evidence reviewed here points clearly toward an integrative approach — one that treats nutrition, movement, sleep, stress, emotional wellbeing, and environmental exposures as an interconnected system. This is how the endocrine system itself works: the gut shapes oestrogen metabolism; the HPA axis governs reproductive hormone balance; circadian rhythm influences insulin sensitivity. A convergence of lifestyle medicine, yoga, Ayurveda, and contemplative practice — each addressing distinct but complementary mechanisms — offers the most scientifically coherent path forward.

​

This calls for a response on multiple fronts: policy that places hormonal health within prevention agendas; research investment in rigorous integrative trials, particularly in India where the burden is acute and the traditional knowledge base is rich; and health education that equips both clinicians and women themselves with an accurate understanding of how lifestyle shapes hormonal health.

References:

​

  1. World Health Organization. (2025). Building a healthier world by women and for women. who.int/news/item/06-03-2025

  2. GBD 2021 Diseases and Injuries Collaborators. (2025). Global prevalence and trends of gynecological diseases among women of childbearing age. *PMC*. https://pmc.ncbi.nlm.nih.gov/articles/PMC12316229

  3. Ganie MA, Chowdhury S, Malhotra N et al. (2024). Prevalence, phenotypes, and comorbidities of PCOS among Indian women. JAMA Network Open, 7(10):e2440583.

  4. Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012 Dec;33(6):981-1030.

  5. Pasquali R, Gambineri A. Cortisol and the polycystic ovary syndrome. Expert Rev Endocrinol Metab. 2012 Sep;7(5):555-566.

  6. Heydari T, Ramdass PVAK. Circadian rhythm disruption and polycystic ovary syndrome: a systematic review and meta-analysis. AJOG Glob Rep. 2025 Mar 20;5(2):100479.

  7. Sun Y, Gao S, Ye C, Zhao W. Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications. Front Cell Infect Microbiol. 2023 Feb 24;13:1142041.

  8. Mei S, Ding J, Wang K, Ni Z and Yu J (2022) Mediterranean Diet Combined With a Low-Carbohydrate Dietary Pattern in the Treatment of Overweight Polycystic Ovary Syndrome Patients. Front. Nutr. 9:876620.

  9. Cavalcante DCB, Scandolara TB, Kogure GS, Rodrigues C, Verruma CG, de Moraes MO, Dos Reis RM, Cavalcante MB, Furtado CLM. Effects of physical activity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Rev Bras Ginecol Obstet. 2025 Sep 12;47:e-rbgo56.

  10. Donga E, van Dijk M, van Dijk JG, Biermasz NR, Lammers GJ, van Kralingen KW, Corssmit EP, Romijn JA. A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. J Clin Endocrinol Metab. 2010 Jun;95(6):2963-8.

  11. Verma A, Upadhyay V, Saxena V. Effect of Yoga Therapy on Health Outcomes in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Am J Lifestyle Med. 2021 Aug 6;17(1):73-92.

  12. Gautam R, Maan P, Arora A, Nair A, Ganie A, Chellamma J, Leelamma J, Jabbar PK and Arora T (2026) Yoga as a complementary intervention for polycystic ovary Syndrome management: a systematic review. Front. Reprod. Health 8:1753608.

  13. Cramer H, Peng W, Lauche R. Yoga for menopausal symptoms-A systematic review and meta-analysis. Maturitas. 2018 Mar;109:13-25. doi: 10.1016/j.maturitas.2017.12.005. Epub 2017 Dec 6. PMID: 29452777

  14. Pal, A., Nath, B., Paul, S., & Meena, S. (2022). Evaluation of the effectiveness of yoga in management of premenstrual syndrome: a systematic review and meta-analysis. Journal of Psychosomatic Obstetrics & Gynecology, 43(4), 517–525.

  15. Arumugam V, Vijayakumar V, Balakrishnan A, B Bhandari R, Boopalan D, Ponnurangam R, Sankaralingam Thirupathy V, Kuppusamy M. Effects of Ashwagandha (Withania Somnifera) on stress and anxiety: A systematic review and meta-analysis. Explore (NY). 2024 Nov-Dec;20(6):103062.

  16. Chehregosha F, Fakhr L, Tarighat-Esfanjani A, Maghsoumi-Norouzabad L. The effects of fenugreek (Trigonella foenum-graecum) seed on glycemic parameters: An updated systematic review and meta-analysis of randomized controlled trials. Avicenna J Phytomed. 2025 Nov-Dec;15(6):1677-1699.

  17. Patibandla S, Gallagher JJ, Patibandla L, Ansari AZ, Qazi S, Brown SF. Ayurvedic Herbal Medicines: A Literature Review of Their Applications in Female Reproductive Health. Cureus. 2024 Feb 29;16(2):e55240.

  18. Patangia, B. & Sathiyaseelan, A. (2026). Ayurvedic and Siddha interventions for menopausal symptom management: a systematic review and meta-analysis of randomized controlled trials. Health Problems of Civilization, 20(2), 118–141.

  19. Kumar S, Nachankar SR, Kuchewar V, Nimbarte BB, Bhanare RS. Chronobiology And Circadian Rhythm-Based Daily Regimen In Ayurveda - A Comparative Analysis. J Neonatal Surg. 2025;14(8):30-8

  20. Philip ST, Thimmapuram J, Thakur K, et al. Heartfulness meditation alters neuroendocrine profiles: A randomized controlled trial on hormones of stress and well-being. Medicine (Baltimore). 2025 Nov 21;104(47):e45559.

  21. Rao V, Pena A, James A, et al. (2024) The role of meditation and mindfulness in the management of polycystic ovary syndrome: a scoping review. Front. Endocrinol. 15:1295705. doi: 10.3389/fendo.2024.1295705

Back to Knowledge Center

bottom of page